|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
Departments of Medicine (M.E.G.), Biochemistry and Molecular Biology (T.H., Y.-J.F., S.M., C.C.B., V.G.), and Cellular Biology and Anatomy (S.B.S., P.S.G.), Medical College of Georgia, Augusta, Georgia; and Chugai Biopharmaceuticals, Inc., San Diego, California (M.H.)
We evaluated the potential of the Na+- and Cl--coupled amino acid transporter ATB0,+ as a delivery system for amino acid-based prodrugs. Immunofluorescence analysis indicated that ATB0,+ is expressed abundantly on the luminal surface of cells lining the lumen of the large intestine and the airways of the lung and in various ocular tissues, including the conjunctival epithelium, the tissues easily amenable for drug delivery. We screened a variety of
-carboxyl derivatives of aspartate and
-carboxyl derivatives of glutamate as potential substrates for this transporter using heterologous expression systems. In mammalian cells expressing the cloned ATB0,+, several of the aspartate and glutamate derivatives inhibited glycine transport via ATB0,+. Direct evidence for ATB0,+-mediated transport of these derivatives was obtained in Xenopus laevis oocytes using electrophysiological methods. Exposure of oocytes, which express ATB0,+ heterologously, to aspartate
-benzyl ester as a model derivative induced inward currents in a Na+- and Cl--dependent manner with a Na+/Cl-/aspartate
-benzyl ester stoichiometry of 2:1:1. ATB0,+ transported not only the
-carboxyl derivatives of aspartate and the
-carboxyl derivatives of glutamate but also valacyclovir, which is an
-carboxyl ester of acyclovir with valine. The transport of valacyclovir via ATB0,+ was demonstrable in both heterologous expression systems. This process was dependent on Na+ and Cl-. The ability of ATB0,+ to transport valacyclovir was comparable with that of the peptide transporter PEPT1. These findings suggest that ATB0,+ has significant potential as a delivery system for amino acid-based drugs and prodrugs.
Address correspondence to: Dr. Malliga E. Ganapathy, Department of Medicine, Medical College of Georgia, Augusta, GA 30912. E-mail: mganapat{at}mail.mcg.edu
This article has been cited by other articles:
![]() |
C. M. H. Anderson, V. Ganapathy, and D. T. Thwaites Human solute carrier SLC6A14 is the {beta}-alanine carrier J. Physiol., September 1, 2008; 586(17): 4061 - 4067. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Srinivas, P. D. Prasad, N. S. Umapathy, V. Ganapathy, and P. S. Shekhawat Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+ Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1046 - G1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Thwaites and C. M. H. Anderson H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine Exp Physiol, July 1, 2007; 92(4): 603 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hatanaka, Y. Hatanaka, and M. Setou Regulation of Amino Acid Transporter ATA2 by Ubiquitin Ligase Nedd4-2 J. Biol. Chem., November 24, 2006; 281(47): 35922 - 35930. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bridges and R. K. Zalups System B0,+ and the Transport of Thiol-S-Conjugates of Methylmercury J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 948 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Van Winkle, J. K. Tesch, A. Shah, and A. L. Campione System B0,+ amino acid transport regulates the penetration stage of blastocyst implantation with possible long-term developmental consequences through adulthood Hum. Reprod. Update, March 1, 2006; 12(2): 145 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Bhardwaj, D. Herrera-Ruiz, P. J. Sinko, O. S. Gudmundsson, and G. Knipp Delineation of Human Peptide Transporter 1 (hPepT1)-Mediated Uptake and Transport of Substrates with Varying Transporter Affinities Utilizing Stably Transfected hPepT1/Madin-Darby Canine Kidney Clones and Caco-2 Cells J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Lorenzi, C. P. Landowski, X. Song, K. Z. Borysko, J. M. Breitenbach, J. S. Kim, J. M. Hilfinger, L. B. Townsend, J. C. Drach, and G. L. Amidon Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1-({beta}-D-ribofuranosyl)benzimidazole Enhance Metabolic Stability in Vitro and in Vivo J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 883 - 890. [Abstract] [Full Text] [PDF] |
||||